StockData
Alkermes plc. logo

Alkermes plc. (ALKS) income statement

ALKSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 5/30208% above fair value
$45.45−1.08 (-2.32%)

Close on Nov 17, 2026Market cap $7.62BP/E 119.6Yield –

Alkermes plc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
84.6%
Operating margin
7.0%
Net margin
4.0%
Return on equity, FY2025
14.7%

Financial strength

Current ratio
2.30
Debt to equity
0.83
Debt to assets
34.2%
Cash to current liabilities
77.3%

Valuation

P/E ratio
119.6
Price to sales
4.57
Price to book
4.22
Dividend yield
–

See a number that looks wrong?